ADA Scientific Sessions 2025 Abstract
Early Glycemic Improvement When Switching to iGlarLixi from Premixed Insulins (PI) in Adults with Type 2 Diabetes (T2D)—A Post Hoc Analysis of Soli-SWITCH
Trial in peopleInterventions
The paper
Prague
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, poster 805-P



